GLP-1 / GIP dual agonist (research)
Tirzepatide
Lyophilized research peptide
Synthetic dual GLP-1 / GIP receptor agonist studied in vitro for combination incretin-pathway research. ≥99% HPLC. Research use only.
Lab name and RUO acknowledgment are collected at checkout.
Lot documentation
Every shipment includes the lot-specific certificate of analysis — HPLC purity (≥99% typical), mass-spec identity, net peptide content, water content, and residual solvents.
Identity & specifications
- Common name
- Tirzepatide (LY3298176)
- Class
- GLP-1 / GIP dual receptor agonist, acylated
- Molecular formula
- C225H348N48O68
- Molecular weight
- 4,813.45 g/mol
- Appearance
- White lyophilized powder
- Purity (HPLC)
- ≥ 99%
- Solubility
- Soluble in slightly alkaline lab buffers
Tirzepatide in research
Tirzepatide is a 39-amino-acid synthetic peptide engineered as a dual agonist at GIPR and GLP-1R, carrying a C20 di-acid fatty-acid modification for extended pharmacokinetics in published research models. The peptide is studied in vitro for cAMP signaling at GIPR vs GLP-1R, downstream β-cell line responses, and combination metabolic pathway work.
Identity
Each lot ships with ≥99% HPLC purity, MS identity verification covering backbone and acyl-group, and net peptide content on the CoA.
Storage and handling
Hold lyophilized vials at -20 °C in original packaging away from light. Reconstitute in lab-grade slightly alkaline buffer; aliquot before freezing.
Documentation
CoA + lot batch records on file by SKU.
Research guide
Tirzepatide research overview
Tirzepatide is listed as a research-use-only material for qualified laboratory programs. This page connects the product listing with identity fields, storage context, CoA review, and long-form research resources so procurement and QA reviewers can evaluate the SKU without relying on a thin commerce page.
The catalog classifies this material as GLP-1 / GIP dual agonist (research), which helps labs compare it with adjacent research peptides, organize internal inventory, and build study-specific reference groups.
Key identity fields
- Common name
- Tirzepatide (LY3298176)
- Class
- GLP-1 / GIP dual receptor agonist, acylated
- Molecular formula
- C225H348N48O68
- Molecular weight
- 4,813.45 g/mol
- Appearance
- White lyophilized powder
- Purity (HPLC)
- ≥ 99%
Storage and handling context
For long-tail stability searches, Tirzepatide should be evaluated in the context of lyophilized storage, reconstitution buffer choice, aliquot planning, freeze-thaw limits, and lot-specific CoA conditions. Always follow institutional SOPs and the documentation attached to the received lot.
Mechanism context
Tirzepatide should be described through published model-system language: receptor family, pathway context, assay controls, concentration planning, and lot traceability. Avoid transferring assumptions from adjacent peptides without a documented comparison protocol.
Search intent covered
- Tirzepatide storage and stability
- Tirzepatide CoA and identity
- Tirzepatide mechanism research
- Tirzepatide comparison resources
Product FAQ
Is Tirzepatide intended for clinical programs?
No. BluGen listings are research use only (RUO) materials for qualified laboratory programs, not clinical, diagnostic, therapeutic, veterinary, food, drug, or cosmetic use.
What documentation is available for Tirzepatide?
Lot-level documentation may include CoA, HPLC purity, MS identity confirmation, net peptide content, and batch records where available for the SKU and lot.
How should lyophilized Tirzepatide be stored?
Store sealed lyophilized vials cold, dry, and protected from light unless the lot CoA or institutional SOP specifies another condition. Reconstituted material should be aliquoted according to the lab protocol.
Where can I learn more about Tirzepatide research context?
See the BluGen research guide for mechanism context, stability notes, storage considerations, and related peptide comparisons: https://getblugen.com/research/research-guide-tirzepatide/
What is the research category for Tirzepatide?
Tirzepatide is categorized as GLP-1 / GIP dual agonist (research) for catalog organization, internal linking, and related research comparisons.
What sequence is listed for Tirzepatide?
Sequence identity should be verified against the lot-specific CoA and product identity table before release into a research workflow.
What molecular weight is listed for Tirzepatide?
The listed molecular weight for Tirzepatide is 4,813.45 g/mol. Use the lot CoA and net peptide content when calculating research stock concentrations.
Does Tirzepatide require cold storage?
Most lyophilized research peptides are stored cold, dry, sealed, and protected from light unless the lot CoA or institutional SOP states otherwise.
How should reconstituted Tirzepatide be handled?
Reconstituted research stocks should be labeled with SKU, lot, solvent, concentration, date, and technician initials, then aliquoted according to the lab protocol to limit freeze-thaw history.
Can lots of Tirzepatide be mixed together?
Avoid mixing lots unless a written protocol requires it. Mixed-lot stocks reduce traceability and make CoA review more difficult.
What purity documentation matters for Tirzepatide?
HPLC purity, MS identity, net peptide content, moisture or residual summaries where available, and lot number alignment are the core documentation checks.
What does net peptide content mean for Tirzepatide?
Net peptide content accounts for peptide mass apart from water and counter-ion contribution. It is important for molarity calculations in laboratory records.
What should procurement review before ordering Tirzepatide?
Procurement should review SKU, vial size, lot documentation path, RUO status, storage requirements, shipping expectations, and any internal approval requirements.
How should Tirzepatide be cited in a method record?
Record supplier, SKU, lot number, CoA document ID, reconstitution solvent, stock concentration, storage condition, and date prepared.
What are common related resources for Tirzepatide?
Related resources include the peptide storage guide, reconstitution guide, CoA reading guide, purity guide, and any comparison articles linked from the product page.
Why does BluGen link Tirzepatide to research articles?
Internal article links help buyers evaluate identity, storage, documentation, and research context without relying on a thin product listing.
What should be done if Tirzepatide documentation is incomplete?
Hold the lot in review and request the missing CoA or batch documentation before releasing the material into an internal research workflow.
Is Tirzepatide content on BluGen medical advice?
No. BluGen content is laboratory procurement and research documentation content for RUO materials only.
Related research resources
Reference path
- Lot CoA: verify HPLC purity, MS identity, and net peptide before release.
- Internal SOP: record storage, reconstitution, concentration, and aliquot history.
- Reconstitution calculator: convert vial size + diluent to concentration
- Article links: file the product guide, glossary definition, storage guide, and comparison page beside procurement notes.
- Search PubMed for Tirzepatide research
Research use only (RUO)
This material is sold for laboratory research purposes only. It is not for clinical, diagnostic, therapeutic, or veterinary application, and not for food, drug, or cosmetic use where restricted.